TeacherMitra.com
Dictionary
Dictionary
allow_url_fopen is ENABLED
Dictionary Search
Go Find!
vanda
Synonyms
Noun
1. orchid
2. orchidaceous plant
Usage
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years - PR Newswire
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Vanda Wins Rare US FDA Hearing As Years-Long Saga For Hetlioz Jet Lag Indication Continues - Citeline News & Insights
Vanda Pharmaceuticals (VNDA) Is Up 13.3% After Rare FDA Hearing Granted on HETLIOZ Jet Lag Bid - simplywall.st
CHMP backs drugs from Novartis, Crinetics while Vanda gets a thumbs down - FirstWord Pharma
Vanda Pharmaceuticals Becomes Presenting Sponsor of Men’s Basketball Season and Smith Center Celebration - George Washington University Athletics
Vanda Pharmaceuticals Becomes Presenting Sponsor Of University Of Maryland Basketball - University of Maryland Athletics
Vanda, with FDA nod for Bysanti, gains 2nd new drug approval in as many months - Fierce Pharma
FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus - Pharmaceutical Technology
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Sees Significant Growth in Short Interest - MarketBeat
Biopharma bites: Vanda gets sought-after hearing, plus ICER's Entyvio report and more from Disc, QL Biopharma - FirstWord Pharma
FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid - Fierce Pharma
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation - PR Newswire
Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness - PR Newswire
Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference - PR Newswire
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder - PR Newswire
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - PR Newswire
Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire
Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting - PR Newswire
Tribute Wall | Vanda Simmons - floralhaven.com
Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration - PR Newswire
US FDA approves Vanda's antipsychotic pill, shares climb - Reuters
Oil’s war-driven volatility pulls in record retail money, fueling 'meme-style' trading - CNBC
Watch Vanda Insights on Oil Markets, IEA Report - Bloomberg.com
Vanda Ends 40-Year Motion Sickness Drug Drought With FDA Approval for Nereus - BioSpace
After years of dispute with FDA, Vanda will get a public hearing for jet lag drug - Endpoints News
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results - PR Newswire
Vanda Rebounds From Jet Lag Rejection With FDA Nod for Bipolar, Schizophrenia Drug - BioSpace
Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results - PR Newswire
Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera - PR Newswire
FDA Accepts Vanda Pharmaceuticals’ BLA for Imsidolimab in Generalized Pustular Psoriasis - Dermatology Times
Vanda Pharmaceuticals (NASDAQ: VNDA) CEO outlines DTC channel for FDA-approved motion drug - Stock Titan
Vanda scores FDA approval for oral antipsychotic Bysanti - FirstWord Pharma
Vanda tackles Wegovy-driven vomiting, sparking race to ph. 3 - Fierce Biotech
Vanda Pharma: High Risk, Heavily Discounted - Stock Ahead Of PDUFA This Week (NASDAQ:VNDA) - Seeking Alpha
After court win, Vanda reaches accord with FDA on Hetlioz, tradipitant reviews - FirstWord Pharma
FDA lifts partial hold on Vanda’s motion sickness drug following dispute resolution - FirstWord Pharma
US FDA approves Vanda Pharmaceuticals' motion sickness drug - Reuters
Vanda's motion sickness drug, Agios' thalassemia treatment make the grade with FDA - Fierce Pharma
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder - PR Newswire
Vanda's shares drop after 2nd FDA rejection for Hetlioz in jet lag disorder - Fierce Pharma
Vanda secures win in regulatory showdown as FDA agrees to review jet lag drug - The Business Journals
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley - Yahoo Finance
Vanda's tradipitant halves vomiting rate in patients taking Wegovy - FirstWord Pharma
Vanda Slides After FDA Again Rejects Hetlioz For Jet Lag - BioSpace
Vanda and the FDA make nice, agreeing to squash several disputes following appeals court win - Fierce Pharma
Capitals Announce Vanda Pharmaceuticals as Official Zamboni Partner | Washington Capitals - NHL.com
FDA again rejects Vanda's Hetlioz for jet lag disorder - FirstWord Pharma
Vanda signs on as NHL's 1st pharma patch sponsor in Islanders deal, inks DC arena partnership - Fierce Pharma
FDA Sends Decision Letter to Vanda Pharmaceuticals for NDA of Hetlioz - Pharmaceutical Executive
FDA clock runs slightly longer on re-review of hold on Vanda's tradipitant - FirstWord Pharma
Vanda Pharmaceuticals secures public FDA Hearing for Hetlioz - GxP News
Vanda Seeks FDA Commissioner Review of Outgoing CDER Director's Decision to Uphold Approval of Two Generic Versions of Hetlioz® - PR Newswire
Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years - Morningstar
Vanda Pharmaceuticals (NASDAQ:VNDA) Sets New 52-Week High - What's Next? - MarketBeat
FDA grants first drug approval hearing in 40 years over jet lag pill - Stock Titan
Vanda Pharmaceuticals Signs on as Sponsorship Partner for Georgetown Men’s and Women’s Basketball Games - Georgetown University Athletics
Obituary for Vanda Lou (Miller) Powers - J.C. Green & Sons | Funeral Home Thomasville NC
Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus (NASDAQ:VNDA) - Seeking Alpha
Obituary for Vanda Lou Fariss at Reese Funeral Home - Highland Funeral Service
Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena - PR Newswire
Vanda (NASDAQ: VNDA) CMO disposes 30,800 shares to cover RSU taxes - Stock Titan
Executive at Vanda (NASDAQ: VNDA) sells shares to cover RSU taxes - Stock Titan
Vanda Pharmaceuticals: Soaring On Bysanti Approval, But You Shouldn't Feel Dizzy (VNDA) - Seeking Alpha
Vanda (NASDAQ: VNDA) CEO sells 156,235 shares to cover RSU tax obligations - Stock Titan
Vanda Pharmaceuticals price target raised to $14 from $11 at B. Riley - Yahoo Finance
Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial" - PR Newswire
Assessing Vanda Pharmaceuticals (VNDA) Valuation After FDA Approval Of NEREUS For Motion Sickness - Yahoo Finance
Vanda touts 'landmark' win over FDA in yearslong dispute over Hetlioz's jet lag disorder bid - Fierce Pharma
Vanda Pharmaceuticals Stock Jumps After FDA Approves Motion Sickness Drug - Barron's
Vanda and Exante Data Combine in Strategic Merger - Yahoo Finance
Vanda Marie Rigsby Obituary October 21, 2025 - Music Funeral Services
Vanda ends 40-year hiatus for new motion sickness drugs - pharmaphorum
Vanda Stock Draws Heavy Buzz Ahead Of FDA Verdict On Bysanti For Bipolar, Schizophrenia - Stocktwits
[144] Vanda Pharmaceuticals Inc. SEC Filing - Stock Titan
Vanda Mae Mayhue Obituary July 7, 2025 - Evans Funeral Service & Crematory
Vanda Stock Drops 10% Premarket After FDA Rejects Jet Lag Drug Application - Stocktwits
US retail traders buy silver ETFs faster than tech favorites, Vanda Research says - Reuters
Vanda Files BLA for Imsidolimab in Generalized Pustular Psoriasis - Dermatology Times
Vanda’s FDA Moment: A High-Stakes Bet That Could Redefine The Stock - Stocktwits
A Look At Vanda Pharmaceuticals (VNDA) Valuation After FDA Approval Of Bysanti For Bipolar I Disorder And Schizophrenia - simplywall.st
Vanda wraps up year with FDA nod for motion sickness drug - FirstWord Pharma
Stock Movers: Deere, Veris Residential, Vanda Pharmaceuticals - Bloomberg.com
Vanda Pharmaceuticals Leads 3 Promising Penny Stocks - Yahoo Finance
New York Islanders Name Vanda Pharmaceuticals as Team's Jersey Patch Partner in Milestone NHL Agreement - PR Newswire
Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S - PR Newswire
Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results - PR Newswire
Vanda Jumps 21% After FDA Approves Motion Sickness Therapy - Yahoo Finance
Vanda Pharmaceuticals Stock (ISIN: US92178N1054) Faces Heightened Scrutiny Amid Pipeline Setbacks an - AD HOC NEWS
FDA approves Vanda’s Nereus - The Pharmaletter
Vanda replaces Solo Stove as Islanders’ jersey patch - Sports Business Journal
Trending tickers: latest investor updates on Nvidia, Caterpillar, Vanda Pharmaceuticals and Walker Crips - Yahoo Finance UK
FDA approves first new motion sickness vomiting drug in over 40 years - Stock Titan
Monumental Sports & Entertainment Announces Vanda Pharmaceuticals Inc. as Official Partner and Jersey Patch Partner for the Washington Mystics - Monumental Sports
Vanda Pharmaceuticals: SG&A Takes Off, TAM Doesn’t (Rating Downgrade) (VNDA) - Seeking Alpha
Vanda skin disorder drug accepted for FDA review (VNDA:NASDAQ) - Seeking Alpha
Vanda Pharmaceuticals surges as FDA approves Bysanti for bipolar I disorder and schizophrenia - Quiver Quantitative
FDA pushes back on new drug that aimed to ease jet lag for travelers - Stock Titan
Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026 - PR Newswire
Foreign Language Equivalents
Foreign Language Equivalents of 'vanda'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
vand, vandaa, anda, avnda, vamda, vsnda, vanad, vannda, vands, vansa, vandda, vabda, vvanda, vnda, vana, banda, canda, vnada, vanfa, vadna, vada, vaanda
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z